Tango Therapeutics, Inc. (TNGX) Stock Price

TNGXStock

$22.04+140.35%52W

Market Cap$3.72B

P/E—

PEG Ratio—

Div yield—

Beta1.19

TNGX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-18.30%

Price vs S&P 500 (4W)0.03%

VGM Score59.16

Book Value / Share (Quarterly)$6.08

P/TBV (Annual)3.08x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)35.89%

Cash Flow / Share (Quarterly)$-0.86

Price vs S&P 500 (YTD)136.83%

Net Profit Margin (TTM)-151.15%

EPS (TTM)$-0.84

10-Day Avg Trading Volume4.04M

EPS Excl Extra (TTM)$-0.84

EPS (Annual)$-0.87

ROI (Annual)-65.15%

Net Profit Margin (5Y Avg)-268.70%

Cash / Share (Quarterly)$6.02

Revenue Growth QoQ (YoY)363.61%

ROA (Last FY)-41.23%

Revenue Growth TTM (YoY)121.47%

EBITD / Share (TTM)$-0.99

ROE (5Y Avg)-33.14%

Operating Margin (TTM)-165.91%

Cash Flow / Share (Annual)$-1.22

P/B Ratio3.63x

P/B Ratio (Quarterly)4.95x

Net Income / Employee (Annual)$-741,600

EV / Revenue (TTM)50.69x

ROA (TTM)-23.36%

EPS Incl Extra (Annual)$-0.87

Current Ratio (Annual)7.00x

Quick Ratio (Quarterly)49.95x

3-Month Avg Trading Volume3.42M

52-Week Price Return140.35%

Revenue / Employee (TTM)$392,800

Tangible BV / Share (Quarterly)$2.72

P/S Ratio (Annual)59.57x

Asset Turnover (Annual)0.13x

52-Week High$34.39

Operating Margin (5Y Avg)-288.19%

EPS Excl Extra (Annual)$-0.87

26-Week Price Return-8.40%

Quick Ratio (Annual)6.78x

13-Week Price Return-22.83%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)50.82x

Enterprise Value$3.37B

Asset Turnover (TTM)0.26x

Revenue / Employee (Annual)$455,400

Pretax Margin (Annual)-162.85%

Cash / Share (Annual)$2.39

3-Month Return Std Dev61.40%

Net Income / Employee (TTM)$-903,100

ROE (Last FY)-65.15%

EPS Basic Excl Extra (Annual)$-0.87

Receivables Turnover (TTM)36.53x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.84

Receivables Turnover (Annual)12.43x

ROI (TTM)-25.74%

P/S Ratio (TTM)55.88x

Pretax Margin (5Y Avg)-268.32%

Revenue / Share (Annual)$0.54

Tangible BV / Share (Annual)$2.83

Price vs S&P 500 (52W)124.82%

Year-to-Date Return148.76%

5-Day Price Return-8.81%

EPS Normalized (Annual)$-0.87

ROA (5Y Avg)-20.59%

Net Profit Margin (Annual)-162.85%

Month-to-Date Return-11.66%

Cash Flow / Share (TTM)$-1.08

EBITD / Share (Annual)$-0.94

Operating Margin (Annual)-178.39%

ROI (5Y Avg)-33.14%

EPS Basic Excl Extra (TTM)$-0.84

P/TBV (Quarterly)2.78x

P/B Ratio (Annual)1.67x

Pretax Margin (TTM)-150.99%

Book Value / Share (Annual)$1.84

Price vs S&P 500 (13W)-25.51%

Beta1.19x

Revenue / Share (TTM)$0.36

ROE (TTM)-25.74%

52-Week Low$6.69

vGradeD

gGradeA

mGradeB

vgmGradeC

TNGX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.32	-$0.37	-14.23%(-$0.05)
Q1 2026	May 13, 2026	-$0.31	-$0.32	-1.73%(-$0.01)
Q4 2025	Mar 5, 2026	-$0.33	-$0.29	+11.82%(+$0.04)
Q3 2025	Nov 4, 2025	-$0.07	$0.13	+287.37%(+$0.20)
Q2 2025	Aug 5, 2025	-$0.34	-$0.35	-1.93%(-$0.01)

TNGX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

4.33

4.32

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
TNGXTango Therapeutics, Inc.	D	A	B	55.9x	121.5%	—	—	$22.04
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Tango Therapeutics, Inc.

Tango Therapeutics is a precision oncology company developing novel targeted therapies for cancer. The company is advancing PRMT5 inhibitors including TNG462 for non-CNS cancers such as pancreatic and lung cancer, and TNG456, a brain-penetrant inhibitor for CNS cancers including glioblastoma. The pipeline also targets CoREST pathways.

TNGX Next Earnings Report

Report dateNov 4, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.35

Revenue estimate$0

Also reporting on Nov 4, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

TNGX Insider Transactions

SellOct 1, 2026
CRYSTAL ADAM S
Officer
Shares: 27,000Value: $660,796
SellSep 22, 2026
NEWCOMB JESSICA
Officer
Shares: 8,200Value: $198,613
SellSep 1, 2026
CRYSTAL ADAM S
Officer
Shares: 27,000Value: $603,909
SellAug 3, 2026
CRYSTAL ADAM S
Officer
Shares: 27,000Value: $735,517

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for October 2026

Companies in Related Industries

PRMPerimeter Solutions, Inc.Chemicals
DFTXDefinium Therapeutics, Inc. Common SharesPharmaceutical Preparations
CBTCabot CorporationIndustrial Chemicals
ADPTAdaptive Biotechnologies Corporation Common StockBiological Products
IPARInterparfums, Inc. Common StockCosmetics & Toiletries
AVNTAvient CorporationPlastics & Resins
RLAYRelay Therapeutics, Inc. Common StockBiological Products
TARSTarsus Pharmaceuticals, Inc. Common StockBiological Products

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$6.69

High$34.39